CONMED Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by CONMED Corporation on January 12, 2026. The filing serves as a Regulation FD disclosure to announce an investor presentation delivered at the J.P. Morgan Healthcare Conference on the same date.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced investor presentation (Exhibit 99.1) rather than the body of this 8-K report.
Material Changes
No material changes to financial results or operations are detailed in this filing. The document solely references the release of preliminary 2026 financial guidance via an external presentation.
Guidance, Outlook, and Risks
- Guidance: The Company has issued preliminary financial guidance for the year 2026, which is included in the investor presentation available on the company website.
- Legal Status: The information in this report and Exhibit 99.1 is furnished and not deemed "filed" under the Securities Exchange Act of 1934. It is not subject to the liabilities of Section 18 of the Exchange Act or Sections 11 and 12(a)(2) of the Securities Act of 1933.
- Outlook: Specific outlook details are not present in the text; investors must refer to the presentation for forward-looking statements.
Investor Verification Checklist
- Verify the specific figures for the preliminary 2026 financial guidance by accessing the investor presentation (Exhibit 99.1) on the CONMED Corporation website.
- Confirm the date and context of the J.P. Morgan Healthcare Conference presentation.
- Note that the guidance is preliminary and subject to change; review the presentation for any associated risk factors or assumptions.